Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis. Hauser SL, Kappos L, Montalban X, Craveiro L, et al. Neurology 2021 Sep 2. pii: WNL.0000000000012700.

Read + Share

Amedeo Smart

Independent Medical Education

Hauser SL, Kappos L, Montalban X, Craveiro L, et al. Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis. Neurology 2021 Sep 2. pii: WNL.0000000000012700.
PMID: 34475123